How an Israeli biotech startup is plotting growth in Cambridge

Since its founding in Tel Aviv in 2017, neurodegenerative disease startup NeuroSense Therapeutics has been eyeing the U.S. market. Now, the company (Nasdaq: NRSN) is using its local headquarters in Cambridge to anchor its efforts to advance a drug that aims to treat amyotrophic lateral sclerosis (ALS). Read More

Read More

Baker vetoes immigrant license access bill; override vote expected

Gov. Charlie Baker on Friday vetoed a bill making immigrants without legal status eligible to seek state-issued driver’s licenses, saying the Registry of Motor Vehicles, an agency that he oversees, doesn’t have the ability to verify the identities of potential applicants. The House expects to take its override vote on June 8. Read More

Read More